Clinical trial

Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using…

NCT00368589 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00368589
Title Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
Official title A 12 Week, Randomised, Double Blind Study Evaluating the Effects of Low Dose (10mg) and High Dose (80mg) Atorvastatin on Macrophage Activity and Carotid Plaque Inflammation as Determined by Ultra Small Super-Paramagnetic Iron Oxide (USPIO) Enhanced Carotid Magnetic Resonance Imaging (MRI)
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Study type Observational
Conditions Atherosclerotic Carotid Disease, Atheroma, Atherosclerosis
Intervention type Drug
Interventions atorvastatin
Enrollment 47
Start date Jul 1, 2006
Primary completion Aug 1, 2007
Completion Aug 1, 2007
First posted Aug 24, 2006
Last update posted Apr 16, 2015
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies